Can radiologists distinguish prior mammograms with no overt signs of cancer from women who were later diagnosed with breast cancer from the prior mammograms of women reported as normal and subsequently confirmed to be cancerfree? Twenty-three radiologists and breast physicians viewed 200 craniocaudial mammograms for a half-second and rated whether the woman would be recalled on a scale of 0 (clearly normal) to 100 (clearly abnormal). The dataset included five categories of mammograms, with each category containing 40 cases. The categories were Cancer (current cancer-containing mammograms), Prior-Vis (prior mammograms with visible cancer signs), Contra (current 'normal' mammograms contralateral to the cancer), Prior-Invis (priors without visible cancer signs), and Normal (priors of normal cases). For each radiologist, four pairs of analyses were performed to evaluate whether the radiologists could distinguish mammograms in each category from the normal mammograms: Cancer vs Normal, Prior-Vis vs Normal, Contra vs Normal, and Prior-Invis vs Normal. The Area under Receiver Operating Characteristic curves (AUC) was calculated for each paired grouping and each radiologist. Wilcoxon Signed Rank test showed the AUC values were above-chance for all comparisons: Cancer (z=4.20, P<0.001); Prior-Vis (z=4.11, P<0.001); Contra (z=4.17, P<0.001); Prior-Invis (z=3.71, P<0.001). The results suggest that radiologists can distinguish patients who were diagnosed with cancer from individuals without breast cancer at an above-chance level based on a half-second glimpse of mammogram even before the lesion becomes apparently visible (Prior-Invis). Apparently, something about the breast parenchyma can look abnormal before the appearance of a localized lesion.
INTRODUCTION
Breast cancer is the most commonly diagnosed cancer and leading cause of cancer-related deaths among women worldwide [1] . Despite an increasing incidence rate, the breast cancer mortality rate has been decreasing over the past few decades. Screening mammography and improvements in treatments could be two main contributing factors in this reduction [2] . However, the sensitivity of digital mammography varies from approximately 50% to 88%, whilst specificity varies from 75% to 88% [3, 4] . Therefore, a substantial number of cancers are missed on screening, with error rates increasing up to 50% depending on the type of lesion present in the mammogram, age of the woman and the level of mammographic density [5, 6] . In addition, some women whose mammogram shows no apparent sign of cancer are often diagnosed with the disease less than 12 months later (interval cancer). Interval cancer may be due to the composition of a woman's breast or the nature (subtype, subtlety, size) of the cancer itself, as well as technology and human limitations [7] .
When women are diagnosed with breast cancer, retrospective analyses of previous mammograms that were reported as normal might either present visible signs of the cancer that were missed or no visible clues. The proportion of previous mammograms showing retrospectively visible clues of malignant change that were incorrectly reported as normal when first examined has been reported to vary between 30% and 67% [8] . These findings raise the question of whether previous mammograms of women that were reported as normal but later confirmed to be malignant at subsequent screen and biopsy contain information that indicates a heightened risk of a future malignant event.
Previous studies showed that radiologists were able to detect lesions in chest radiographs and mammograms at above chance levels with less than a second glimpse of the image [9] . This instantaneous perception of changes relating to an abnormality in an image is known as a 'gist' response and refers to the perceptual information that an observer receives from a momentary glimpse of the image [9] . In medical image perception, the gist response can be inappropriately cancelled out following more detailed image evaluation. In early work by Kundel and Nodine [9] , it was hypothesized that visual search initiates with a global response that determines content, identifies gross deviations from normal and constrains future eye movements. Evans et al [10] reported that experts could classify cases as normal or abnormal at above chance levels by detecting a "global gist signal" that was not based on accidental attention to a localized target in the image. Some of the strongest evidence for this claim came from studies of mammograms [10] [11] [12] [13] in which radiologists classified mammograms from the breast contralateral to the breast with overt disease. Clearly, an ability to discriminate these images from normal mammograms cannot be based on a localized target. These results suggest that might be possible to detect a gist signal in mammograms of women who will eventually go on to develop overt disease.
In this study, we investigated whether "the gist of the abnormal" is present in prior mammograms of women that were reported as normal, but later diagnosed with breast cancer at subsequent screening. If the gist of the abnormal is present on the prior mammograms belonging to women who are diagnosed with breast cancer at a subsequent screening, and could be sensed by the radiologists, they should be able to identify these images at above-chance level after a halfsecond presentation of mammograms. We included prior mammograms both with and without overt signs of cancer in this study and evaluated whether the radiologists could distinguish these mammograms from normal mammograms at above-chance level.
MATERIALS AND METHODS

Participants
Twenty-three Royal Australian & New Zealand College of Radiology (RANZCR) certified breast radiologists and breast physicians viewed 200 craniocaudial mammograms for a half-second and rated whether they would call back the woman on a scale of 0-100, with 0 and 100 indicating complete confidence that the cases were normal and abnormal respectively. The participants were attending the RANZCR Breast Imaging Group (BIG) general meeting in 2017 and ethical approval was granted by the University of Sydney. They were asked to provide their demographic information which included gender, age, years since qualification as radiologists, years since registration as breast screening radiologists, number of cases per week, and number of hours per week currently spent reading mammograms. They were also asked whether they had completed any breast reading fellowship which lasted for 3-6 months and whether they were working for Australia or New Zealand screening program. The characteristics of participants are shown in Table 1 .
Case set
The mammograms were acquired by digital technology and de-identified after being collected from BreastScreen New South Wales Digital Breast Image Library. Malignant cases were biopsy proven while negative cases were assessed by the consensus reading of at least two senior radiologists following the negative screen reports of two clinical radiologists. Only Cranial Caudal (CC) view was included in the study. The dataset included five categories of mammograms:
i. Cancer: Current mammograms of women (n=40) with visible signs of cancer that were confirmed to be malignant through biopsy;
ii. Prior-Vis: Prior mammograms of women (n=40) with visible signs of cancer that were reported as normal, but later confirmed to be malignant at subsequent screen and biopsy;
iii. Contra: Current mammogram of the normal breast from women (n=40) with a biopsy-proven cancer reported in the opposite breast;
iv. Prior-Invis: Prior mammograms of women (n=40) with no visible signs of cancer that were reported as normal, but whose most recent mammograms displayed a biopsy-proven cancer;
v. Normal: Prior mammograms of women (n=40) reported as normal and confirmed to be cancer-free using subsequent mammograms obtained two years later. These mammograms served as a baseline for comparison with women diagnosed with cancer. 
Data collection Protocol
In-house MATLAB-based computer application for presenting the images was used. First, a cross appeared in the center of the screen for 500 milliseconds, this was then followed by 500 milliseconds presentation of a unilateral mammogram (CC view). After this, a white breast mask appeared in the region of the mammogram for 500 milliseconds followed by a rating interface when readers were asked to rate whether the image presented was normal or abnormal. Figure 1 shows the experiment procedure. As depicted, a breast mask was presented right after displaying the target. This so-called visual masking makes sure that the participants do not continue to process the image when it has left the screen.
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Prior to the experiment, radiologists were shown how to use the image rating software and a pilot trial using six mammograms was performed to ensure that participants were familiar with the software package. All mammograms were presented to participants in a randomized order and were independently rated by each participant. No feedback was provided to the participants by the software package. Microsoft Surface Pro 4 was used for running the MATLAB-based application and the radiologists were able to use the touch screen to set the slider-bar. The surface was connected to a Philips 28-inch LED (Model 288P6LJEB) display with a resolution of 3840x2160 pixels and a typical brightness of 300 cd/m². The images were resized so that they fit into the display size. The ambient illumination was less than 10 lux and was kept to a level that was comfortable for the radiologists
Analysis
Four pairwise classifications were done based on values of the area under Receiver Operating Characteristic (ROC) curves (AUC). To do so, mammograms belonging to Normal group served as a baseline (Negative instances) and were compared to other four categories. Therefore, for each participant, four comparisons were made between Cancer vs Normal, Contra vs Normal, Prior-Vis vs Normal, and Prior-Invis vs Normal. Each time 80 instances were involved, 40 images of which were negative (Normal), whilst 40 images were exclusively from one of the 4 other categories described above. We used Wilcoxon Signed Rank test to examine whether the AUC estimate for the readers was different from chance level (i.e. 0.5). A significant difference for each comparison indicated that the average reader can distinguish abnormal cases from normal ones at an above-chance level based on gist responses. Figure 1 . Experiment procedure; (1) a cross appeared in the center of the screen for a half-second; (2) the mammogram is presented for a half-second; (3) a white breast mask appeared in the region of the mammogram for a half-second; (4) rating interface to score whether the image presented was normal or abnormal.
RESULTS
The distribution of AUC values across 23 readers for different pairwise classification is shown in Figure 2 . Wilcoxon Signed Rank test results showed that the AUC values were above-chance for each of the four categories: Cancer category (Signed rank=276, z=4.20, P<0.001); Contra category (Signed rank=275, z=4.17, P<0.001); Prior-Vis (Signed rank=273, z=4.11, P<0.001); Prior-Invis (Signed rank=260, z=3.71, P<0.001). The ROC curves for the best performing reader for each pairwise classifications are shown in Figure 3 . 
CONCLUSION
In this paper, the existence of the gist of the abnormal was investigated in the prior mammograms from women who were diagnosed with the cancer at a subsequent screening. The obtained results suggest that the average reader is able to distinguish prior mammograms from women who were diagnosed with the cancer at a subsequent screening, from individuals without breast cancer at an above-chance level based on a half-second glimpse of mammogram even before the lesion becomes apparently visible (Prior-Invis). This means that some women who will be diagnosed with breast cancer in the future may be identified even before lesions become visible and the global gist signal contains information that may predict future malignant events. It may be possible to embed this gist response into risk assessment models by identifying women at high risk, so that screening pathways can be tailored to facilitate early detection of the disease and personalized medical strategies can be implemented.
